Hepion Pharmaceuticals (HEPA) director Danina Fisher files initial Form 3
Rhea-AI Filing Summary
Hepion Pharmaceuticals, Inc. director Danina Fisher filed an initial Form 3, which is the required statement of beneficial ownership for insiders. This filing lists Fisher as a director but shows no reported transactions or holdings data in the available summary fields.
Positive
- None.
Negative
- None.
Key Figures
Buy transactions reported: 0
Sell transactions reported: 0
Derivative transactions reported: 0
3 metrics
Buy transactions reported
0
Form 3 transaction summary buyCount
Sell transactions reported
0
Form 3 transaction summary sellCount
Derivative transactions reported
0
Form 3 transaction summary derivativeTransactionCount
Key Terms
Form 3, reporting insider, ten percent owner
3 terms
Form 3 regulatory
"Danina Fisher filed an initial Form 3, which is the required statement of beneficial ownership"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
reporting insider regulatory
"The Form 3 establishes Danina Fisher as a reporting insider of Hepion Pharmaceuticals"
ten percent owner regulatory
"She is not listed as an officer and is not marked as a ten percent owner"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does Danina Fisher’s Form 3 mean for HEPA investors?
The Form 3 establishes Danina Fisher as a reporting insider of Hepion Pharmaceuticals. It is an initial ownership statement and, in this case, shows no reported transactions in the provided summary data.
Does the HEPA Form 3 for Danina Fisher show any stock transactions?
No, the Form 3 summary shows no buy, sell, or other transactions. All transaction-related counts, including buys, sells, exercises, gifts, and restructurings, are reported as zero in the transaction summary.
What insider role does Danina Fisher have at Hepion Pharmaceuticals (HEPA)?
Danina Fisher is identified as a director of Hepion Pharmaceuticals in the Form 3. She is not listed as an officer and is not marked as a ten percent owner in the provided data fields.
Does the Danina Fisher Form 3 for HEPA indicate any derivative positions?
No, the Form 3 shows an empty derivative summary. The derivativeSummary section contains no remaining options, warrants, or other derivatives based on the information provided.
Are there any footnote disclosures affecting Danina Fisher’s HEPA Form 3?
The footnotes field in the provided data is null, so there are no additional disclosures shown about voting power, investment authority, or related entities beyond the basic role information.